The FDA's breakthrough tag is given to certain medical devices that provide treatment or diagnosis of life-threatening conditions
A large study adds to evidence that people with type O or Rh−negative blood may be at slightly lower risk from the new coronavirus.
Among 225,556 Canadians who were tested for the virus, the risk for a Covid-19 diagnosis was 12 per cent lower and the risk for severe Covid-19 or death was 13 per cent lower in people with blood group O versus those with A, AB, or B, researchers reported on Tuesday in Annals of Internal Medicine.
People in any blood group who were Rh-negative were also somewhat protected, especially if they had O-negative blood.
People in these blood type groups may have developed antibodies that can recognise some aspect of the new virus, co-author Dr. Joel Ray of St. Michael's Hospital in Toronto told Reuters.
"Our next study will specifically look at such antibodies, and whether they explain the protective effect," Ray said. Whether or how this information might influence Covid-19 prevention or treatment is still unclear.
Vitamin D
Low levels of vitamin D have been linked to higher risk for severe Covid-19, but high vitamin D levels do not fix the problem. Increasing vitamin D levels in critically ill patients did not shorten their hospital stay or lower their odds of being moved to intensive care, needing mechanical ventilation, or dying, doctors in Brazil found.
They randomly gave 240 patients hospitalised with severe Covid-19 either a single high dose of vitamin D3 or a placebo. Only 6.7 per cent of patients in the vitamin D group had "deficient" levels of the nutrient, compared to 51.5 per cent of patients in the placebo group, but there was no difference in the outcomes, according to a paper posted on medRxiv ahead of peer review.
The same was true when the researchers focused on the 116 patients with vitamin D deficiency before the treatment.
The authors say theirs is the first randomised trial of its kind to show that vitamin D supplementation "is ineffective to improve hospital length of stay or any other clinical outcomes among hospitalised patients with severe Covid-19."
The FDA's breakthrough tag is given to certain medical devices that provide treatment or diagnosis of life-threatening conditions
The full calendar of DSF events will be unveiled soon
CFIUS extends timeline to review Nippon Steel's US Steel bid
Interior Minister Gerald Darmanin, a staunch Macron ally, says it is 'out of the question' to join or even back a government that raised taxes
US vice-president stresses a two-state solution and Middle East stability in a way that does not empower Iran
John has been influential in reinforcing Dubai’s status as a global trade hub
Among those wounded was Iran's ambassador to Lebanon Mojtaba Amani
Raheem Ali will also be head of partnerships